Funabashi, Japan

Kazuaki Hiraoka


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kazuaki Hiraoka: Innovator in Encephalopathy Detection

Introduction

Kazuaki Hiraoka is a notable inventor based in Funabashi, Japan. He has made significant contributions to the field of information processing, particularly in the detection of encephalopathy. His innovative approach combines advanced technology with medical applications, showcasing the potential of interdisciplinary research.

Latest Patents

Hiraoka holds a patent for a "Non-transitory computer-readable recording medium, encephalopathy determination method, and information processing apparatus." This invention involves a detection device that generates multiple attractors based on brainwave data. The device calculates a Betti number by applying a persistent homology transform to the attractors. Ultimately, it determines the onset of encephalopathy based on a first-order component of a Betti sequence derived from the Betti number. This patent highlights Hiraoka's expertise in merging computational techniques with healthcare solutions.

Career Highlights

Kazuaki Hiraoka is associated with Fujitsu Corporation, where he continues to develop innovative technologies. His work emphasizes the importance of utilizing data analysis in medical diagnostics, paving the way for advancements in patient care. Hiraoka's dedication to research and development has positioned him as a key figure in his field.

Collaborations

Hiraoka collaborates with talented individuals such as Ken Kobayashi and Yuhei Umeda. These partnerships enhance the creative process and contribute to the successful development of groundbreaking technologies.

Conclusion

Kazuaki Hiraoka's contributions to encephalopathy detection through innovative technology exemplify the intersection of computing and healthcare. His work not only advances scientific understanding but also holds promise for improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…